Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Prostate. 2022 May 10;82(12):1176–1185. doi: 10.1002/pros.24369

Figure 2:

Figure 2:

Kaplan-Meier Estimates of Overall Survival Based on Metformin Use, Docetaxel (D) and Androgen Deprivation Therapy (ADT) for Patients with Metastatic Hormone Sensitive Prostate Cancer.